Apexigen Investor Presentation Deck
September 2022, 27 slides
  1. Apexigen
  2. Related Decks
  3. Investor Presentation Decks
corporate overview | Apexigen
forward looking statements disclaimer | Apexigen
leader in discovering and developing innovative therapeutic antibodies against cancer | Apexigen
robust pipeline and partnerships | Apexigen
near term key milestones | Apexigen
management team with deep yale cancer | Apexigen
and pipe provided capital and market access | Apexigen
lead product | Apexigen
targeting a key pathway in stimulating immune response against cancer | Apexigen
was rationally designed for potency and to mimic natural | Apexigen
is differentiated from other agonists | Apexigen
phase programs demonstrate clinical activity across multiple solid tumor types | Apexigen
our most advanced phase programs | Apexigen
phase single agent durable responses in metastatic melanoma | Apexigen
phase durable confirmed responses to combination | Apexigen
patient case study significant response to combination lasting years | Apexigen
phase higher rates for standard of care soc | Apexigen
single dose of turns cold tumor hot data presented at some | Apexigen
ongoing phase durable responses to combination | Apexigen
summary of program | Apexigen
anti | Apexigen
anti reverse immune suppression in and unleash immune mediated tumor killing | Apexigen
has potent anti tumor activity in preclinical models | Apexigen
summary | Apexigen
leader in discovering and developing innovative therapeutic antibodies against cancer | Apexigen
near term key milestones | Apexigen
thank you | Apexigen
See More
Apexigen
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Tumor
Melanoma
Cancer
Recent decks by Apexigen
SPAC
March 2022
See all presentations by Apexigen (2 decks)
Related decks
BioAtla
Investor Conference
June 2022
Erasca
Investor Presentation
November 2023
Alkermes
Results
June 2022
Immatics
Investor Presentation
November 2023
Immatics
Results
October 2022
BioNTech
Results
August 2020
BioNTech
Results
May 2021
BioAtla
Investor Presentation
January 2024
Recent decks by Apexigen
See all presentations (2 decks)
SPAC
March 2022
BioAtla
Investor Conference
June 2022
Erasca
Investor Presentation
November 2023
Alkermes
Results
June 2022
Immatics
Investor Presentation
November 2023
Immatics
Results
October 2022
BioNTech
Results
August 2020
BioNTech
Results
May 2021
BioAtla
Investor Presentation
January 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io